217 related articles for article (PubMed ID: 34269483)
1. Cytosolic GDH1 degradation restricts protein synthesis to sustain tumor cell survival following amino acid deprivation.
Shao J; Shi T; Yu H; Ding Y; Li L; Wang X; Wang X
EMBO J; 2021 Oct; 40(20):e107480. PubMed ID: 34269483
[TBL] [Abstract][Full Text] [Related]
2. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
Long Q; Sun J; Lv J; Liang Y; Li H; Li X
Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
[TBL] [Abstract][Full Text] [Related]
3. LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc.
He J; Li F; Zhou Y; Hou X; Liu S; Li X; Zhang Y; Jing X; Yang L
Cancer Lett; 2020 Jan; 469():419-428. PubMed ID: 31734356
[TBL] [Abstract][Full Text] [Related]
4. α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development.
Wang X; Liu R; Qu X; Yu H; Chu H; Zhang Y; Zhu W; Wu X; Gao H; Tao B; Li W; Liang J; Li G; Yang W
Mol Cell; 2019 Oct; 76(1):148-162.e7. PubMed ID: 31447391
[TBL] [Abstract][Full Text] [Related]
5. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.
Tan J; Wang HL; Yang J; Liu QQ; Li CM; Wang YQ; Fu LN; Gao QY; Chen YX; Fang JY
Theranostics; 2020; 10(13):5763-5777. PubMed ID: 32483417
[No Abstract] [Full Text] [Related]
6. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
[TBL] [Abstract][Full Text] [Related]
7. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
Wang Y; Fu D; Chen Y; Su J; Wang Y; Li X; Zhai W; Niu Y; Yue D; Geng H
Cell Death Dis; 2018 May; 9(5):501. PubMed ID: 29717134
[TBL] [Abstract][Full Text] [Related]
8. MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response.
Xuan F; Huang M; Zhao E; Cui H
Cell Death Dis; 2018 Oct; 9(11):1062. PubMed ID: 30333481
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15.
Duan L; Perez RE; Calhoun S; Maki CG
Cancer Biol Ther; 2022 Dec; 23(1):65-75. PubMed ID: 35100078
[TBL] [Abstract][Full Text] [Related]
10. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
11. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
[TBL] [Abstract][Full Text] [Related]
14. Redirected nuclear glutamate dehydrogenase supplies Tet3 with α-ketoglutarate in neurons.
Traube FR; Özdemir D; Sahin H; Scheel C; Glück AF; Geserich AS; Oganesian S; Kostidis S; Iwan K; Rahimoff R; Giorgio G; Müller M; Spada F; Biel M; Cox J; Giera M; Michalakis S; Carell T
Nat Commun; 2021 Jul; 12(1):4100. PubMed ID: 34215750
[TBL] [Abstract][Full Text] [Related]
15. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
[TBL] [Abstract][Full Text] [Related]
16. PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.
Abu Aboud O; Donohoe D; Bultman S; Fitch M; Riiff T; Hellerstein M; Weiss RH
Am J Physiol Cell Physiol; 2015 Jun; 308(11):C890-8. PubMed ID: 25810260
[TBL] [Abstract][Full Text] [Related]
17. Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.
Hong Z; Li H; Li L; Wang W; Xu T
Cancer Biomark; 2017; 18(2):125-131. PubMed ID: 27983522
[TBL] [Abstract][Full Text] [Related]
18. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
19. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HOTAIR promotes metastasis of renal cell carcinoma by up-regulating histone H3K27 demethylase JMJD3.
Xia M; Yao L; Zhang Q; Wang F; Mei H; Guo X; Huang W
Oncotarget; 2017 Mar; 8(12):19795-19802. PubMed ID: 28177890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]